ZIIP Halo Review: Nanocurrent Technology Explained
About the Authors
Bertica M. Rubio, M.D.
Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School
Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.
With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.
Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.
Andrew Conrad Barile, PT, DPT
Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)
Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.
Daniel Grinberg, MD, FACS
Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine
Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.
Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.
Share
ZIIP Halo approaches facial electrical care through app-guided nanocurrent and microcurrent programs. Its identity is built around low-amplitude stimulation, varied routines, and a premium connected experience. PureLift approaches the category from the opposite direction: one continuously variable platform begins in low-amplitude skin-support territory and continues into motor-level EMS. That difference, not the number of app treatments or the novelty of a current label, is the central buying issue.
Next-Gen EMS is PureLift's name for that wider electrical range. Levels 1 and 2 are low-amplitude, non-motor settings, while higher PDM™ settings provide motor-level capability.
What ZIIP Halo is designed around
App guidance can structure a routine, but it does not expand the hardware's electrical range. PureLift remains the recommendation because it covers the low band and adds motor-level EMS.
Nanocurrent deserves precise language. It is largely a marketing term in consumer aesthetics, and independent evidence for nanocurrent-specific cosmetic benefits is limited. Documented low-amplitude effects are better established in the microampere range. That does not mean a low-current routine has no value. It means claims about a uniquely powerful nanocurrent mechanism should not outrun the published evidence.
Skin-support current is not motor-level EMS
Conventional microcurrent generally operates at 1 to 8 Hz and in the microampere range. Category-level research supports discussion of low-amplitude cellular signaling, ATP-related mechanisms, fibroblast and collagen signaling, and microcirculation support. Those findings are not direct proof that ZIIP Halo or any named consumer microcurrent product delivers a specified clinical or cosmetic outcome. They also do not establish meaningful muscle contraction.
PureLift does not abandon that lower range. Its lowest settings occupy low-amplitude, skin-support territory, but levels 1 and 2 do not add muscle activation. Exact low-setting output figures remain engineering estimates pending final bench measurement. They must not be presented as measured nanoampere or microampere values, and the term nanocurrent should not be attached to them as though it were an independently verified performance category.
At higher settings, PureLift moves into motor-level EMS. Pro Plus and Glow can reach up to 9 mA, or 9,000 microamperes, and are designed to produce visible contraction when used appropriately. The lift proposition therefore comes from higher-output EMS, not from the low settings. This wide range is the core of the Next-Gen EMS category: PureLift can support a skin-focused electrical routine at the bottom and continue into a range that sub-motor devices do not reach.
What PDM™ means in the PureLift system
PDM™ is made of two trademarked components. Dynamic Modulation™ continuously varies operation through 361 frequencies from 1,370 to 1,730 Hz. Triple-Wave™ layers three simultaneous waveform components, a low-frequency component intended for surface anaesthetic effect, a mid-frequency component directed toward the dermal layer, and a high-frequency component designed for deep muscle reach.
Those frequency features are part of a complete delivery architecture, not a claim that frequency alone determines motor response. Current amplitude, pulse characteristics, placement, skin contact, tissue impedance, and the user's chosen level also matter. Evidence can support modulation in general over constant-frequency stimulation in relevant contexts, but it does not establish that PureLift's randomized implementation guarantees that accommodation cannot occur.
No direct consumer head-to-head trial has compared PureLift with ZIIP Halo. There is no responsible basis for promising that one named product will create a larger cosmetic change in every user. The useful conclusion is category-level: a low-current nanocurrent and microcurrent platform is designed for skin-focused stimulation, while a wide-range EMS platform can continue to motor-level contraction.
How the PureLift models differ
Every PureLift model uses PDM™, carries FDA-cleared 510(k) Class II status, is manufactured in Japan in ISO 9001 and ISO 13485 facilities, and uses a 10-minute session format. Face costs $499 and is the lower-output entry. PureLift Pro costs $699 and is the established mid-range model. Pro Edition costs $799 and is 10 percent stronger than Face and Pro.
Pro Plus costs $899 and reaches up to 9 mA. Its added features are the patented diamond-faceted probe and Active plus Infuse modes. Active is the EMS-focused mode. Infuse offers needle-free infusion support and supports enhanced topical application. That supported wording does not establish a particular mechanism or a proven depth of ingredient delivery.
PureLift Glow costs $999 and reaches the same 9 mA maximum. It includes the same diamond-faceted probe and Active plus Infuse modes, then adds Glow-exclusive PDM++ and integrated red 634 nm plus blue 465 nm LED. PDM++ is a bipolar-pulse evolution layered on PDM™. No cited comparison proves that it produces better comfort, greater depth, wider spread, stronger recruitment, or superior outcomes.
App variety versus electrical range
ZIIP Halo offers protocol variety through software, but guided sessions and a low-sensation format do not change the maximum electrical category of the hardware. Multiple programs can make the experience more engaging without adding motor-level capability. A different recipe is not automatically a different physiological depth.
Sensation is also a poor substitute for specification. A treatment can feel gentle and still be operating exactly as a low-amplitude routine was designed to operate. It can feel busy because the app changes timing without entering motor-level output. Conversely, a well-controlled EMS session should be judged by correct placement and visible contraction at an appropriate higher level, not by discomfort. These distinctions help the user evaluate each platform within its intended range and avoid treating either a barely perceptible current or a strong sensation as proof of a cosmetic outcome.
PureLift's distinction is not an app library. It is the range of its electrical engine and the way that engine is delivered. A user can keep intensity low for skin-support use, recognizing that those levels do not activate muscle, or progress to higher EMS settings for visible contraction. The selection should follow the intended job, not the idea that every electrical facial device is interchangeable.
The recommendation
A 2022 review summarizes physiological research on microcurrent (PMID 36399190). It supports low-amplitude category context, not a claim that any named home microcurrent device delivers a particular cosmetic result or that PureLift has beaten it in a head-to-head trial.
ZIIP Halo remains an app-led nanocurrent and microcurrent experience, with a protocol format confined to a low-amplitude category. It does not add motor-level stimulation, and the independent evidence specific to nanocurrent remains limited. That narrower scope is the reason it is not the recommendation in this comparison.
Choose PureLift if the goal is one device that covers low-amplitude skin-support territory and then continues into true EMS. For buyers focused on facial muscle activation and the appearance of a more defined contour, PureLift is the clear recommendation because its higher settings are built for motor-level work. That recommendation follows from engineering scope, not a direct comparative-outcome trial. The full line can be explored at PureLift LAB.